0-75-1404-993
Table of contents :
Front Matter……Page 1
Introduction……Page 3
Appendix A. (Glossary)……Page 0
Table of Contents……Page 5
A – Z Section……Page 7
A 301 – AN1……Page 8
AN 448 – Antileishmanial Agents……Page 23
Antileprotic Agents – Azulfidine……Page 38
B 306 – BZQ……Page 51
C6 – CEENU……Page 65
Cefacetrile – Clidanac……Page 75
Climaval – Cytoxan……Page 85
D 138 – Dytide……Page 97
E’ – EXPECTORANTS……Page 115
F 2207 – FX 703……Page 126
G/18 – Gynol……Page 136
H 33 – Hytrin BPH……Page 147
I 612 – Ivermectin……Page 159
JB 11 – Kytril……Page 169
3123L – Lyxoascorbic Acid……Page 172
M 99 – Mytelase……Page 183
N 0774 – Nytol……Page 201
Obidoxime Chloride – Ozagrel……Page 219
P2S – Picenadol Hydrochloride……Page 227
Picloxydine – Progynova……Page 236
Proheptazine – PYY……Page 247
Qinghaosu – Quipazine Maleate……Page 258
R200 – Rythmodan……Page 260
S 46 – Syscor……Page 268
T3 – Tyzine……Page 284
U 4191 – UTP……Page 301
Vadocaine – Vumon……Page 304
W 108 – Zyprexa……Page 310
Appendix A. (Glossary)……Page 314
A – CSF……Page 315
CSF-1 – Infarction……Page 324
Infection – Neurogenic……Page 336
Neurogenic Inflammation – Zwitterion……Page 343
Appendix B. (Tables)……Page 358
Reviews
There are no reviews yet.